Episodebeskrivelse
Brazil's health regulator, ANVISA, has just shaken up the digital health landscape. A new draft resolution brings critical clarifications for AI-powered medical software, creating a clearer but much stricter pathway to Latin America's largest market. This move could accelerate innovation for some, while creating major new hurdles for others.
This episode unpacks the critical details of this regulatory shift. We explore the dilemma facing manufacturers of AI-driven diagnostics: the new rules provide a clearer roadmap for approval but demand an unprecedented level of control and documentation…
Website: pureglobal.com

